| Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study (NCT04245644) | Massimo Falconi | 2019-03-02 |
| An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer (NCT03989310) | Chinese PLA General Hospital | 2019-03-01 |
| Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer (NCT03775525) | Genzada Pharmaceuticals USA, Inc. | 2019-03-01 |
| Whipples Resection in Octogenarians (NCT03813368) | University of Edinburgh | 2019-02-20 |
| Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005) (NCT03797326) | Merck Sharp & Dohme LLC | 2019-02-12 |
| EUS-guided Celiac Plexus Neurolysis for the Treatment of Abdominal Pain in Pancreatic Cancer (NCT03940027) | Changhai Hospital | 2019-02-10 |
| Bilioenteric Anastomosis by Magnetic Compressive Technique (NCT03774589) | First Affiliated Hospital Xi'an Jiaotong University | 2019-02-01 |
| Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic Diseases (NCT05193162) | Ruijin Hospital | 2019-02-01 |
| The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study (NCT04075305) | UMC Utrecht | 2019-02-01 |
| Microbial Diversity of Pancreatic Diseases (NCT03809247) | Ruijin Hospital | 2019-02-01 |
| A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC ) (NCT03825328) | Yanqiao Zhang | 2019-01-30 |
| A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies (NCT03829501) | Kymab Limited | 2019-01-28 |
| Mutation of K-RAS, CDKN2A, SMAD4 and TP53 in Pancreatic Cancer: Role of Liquid Biopsy in Preoperative Diagnosis (NCT03524677) | University of Roma La Sapienza | 2019-01-23 |
| Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 Trial (NCT03553004) | University of Kansas Medical Center | 2019-01-22 |
| 9-ING-41 in Patients With Advanced Cancers (NCT03678883) | Actuate Therapeutics Inc. | 2019-01-04 |
| 18F-ASIS PET/CT Imaging of Tissue Factor Expression In Patients With Primary and Metastastic Cancer (NCT03790423) | Rigshospitalet, Denmark | 2019-01-03 |
| Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients (NCT06378853) | Jinling Hospital, China | 2019-01-01 |
| Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer (NCT03621644) | Viewray Inc. | 2019-01-01 |
| Covid-19 Pandemic and Pancreatic Surgery in Italy (NCT04380766) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2019-01-01 |
| A Real-world Study of Albumin-bound Paclitaxel in the Treatment of Pancreatic Cancer (NCT03768687) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2018-12-20 |
| CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer (NCT03699319) | David Bajor, MD | 2018-12-07 |
| Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer (NCT03520790) | Dana-Farber Cancer Institute | 2018-12-05 |
| Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients (NCT03787056) | Hospices Civils de Lyon | 2018-12-04 |
| Paricalcitol Addition to Chemotherapy in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (NCT04054362) | Barts & The London NHS Trust | 2018-11-29 |
| Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic Cancer (NCT03572400) | Do-Youn Oh | 2018-11-29 |
| Lidocaine Infusion in Pancreatic Cancer (NCT04048278) | University of Illinois at Chicago | 2018-11-08 |
| Biodegradable Pancreatic Stents for the Prevention of Postoperative Pancreatic Fistula After Cephalic Pancreaticoduodenectomy (NCT04783831) | Hospital Universitario Virgen de la Arrixaca | 2018-11-01 |
| Chemotherapy, Host Response and Molecular Dynamics in Periampullary Cancer (NCT03724994) | Lund University | 2018-10-30 |
| Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma (NCT03717298) | Catalysis SL | 2018-10-30 |
| Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells (NCT03634501) | Xuanwu Hospital, Beijing | 2018-10-26 |
| SBRT and Anti-programmed Cell Death Protein 1(Anti-PD-1) in Late Stage or Recurrent Pancreatic Cancer Patients (NCT03716596) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2018-10-22 |
| Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma (NCT03704662) | Medical College of Wisconsin | 2018-10-22 |
| The Genetic Education for Men Trial: Web-Based Education vs. Standard Care (NCT02957981) | Georgetown University | 2018-10-01 |
| Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas (NCT03153410) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-09-27 |
| U01-Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer (NCT03886571) | Hoag Memorial Hospital Presbyterian | 2018-09-15 |
| Multiple Arterial Phase Computed Tomography Examination to Improve Detection of Tumors in the Liver and Pancreas (NCT04813432) | Karolinska Institutet | 2018-09-10 |
| A Clinical Study of AL2846 Capsule Combined With Gemzar Injection in the Treatment of Advanced Pancreatic Cancer (NCT06278493) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2018-08-23 |
| Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors (NCT03662204) | Exact Sciences Corporation | 2018-08-23 |
| Niraparib in Patients With Pancreatic Cancer (NCT03601923) | Dana-Farber Cancer Institute | 2018-08-22 |
| A Study of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or Metastatic RAS-mutant Solid Tumors (NCT03637491) | Pfizer | 2018-08-15 |
| Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer (NCT03563248) | Massachusetts General Hospital | 2018-08-10 |
| QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers. (NCT03552718) | NantBioScience, Inc. | 2018-08-10 |
| HOPE - A Study to Evaluate the Effect of a Prehabilitation Program on GI Cancer Patients Planning to Undergo Surgery (NCT03642093) | Siobhan Trotter | 2018-08-01 |
| Acquisition of Portal Venous CTCs and Exosomes From Patients With Pancreatic Cancer by EUS (NCT03821909) | Ying Lv | 2018-08-01 |
| CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer (NCT03517176) | Lisata Therapeutics, Inc. | 2018-07-31 |
| Study of Nivolumab, Cabiralizumab, and Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Unresectable Pancreatic Cancer (NCT03599362) | NYU Langone Health | 2018-07-31 |
| Kinetics of Microparticles Under Chemotherapy in Patients With Gastric or Pancreatic Cancer (NCT03471468) | Poitiers University Hospital | 2018-07-23 |
| QUILT-3.080: NANT Pancreatic Cancer Vaccine (NCT03586869) | ImmunityBio, Inc. | 2018-07-17 |
| Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic Cancer (NCT03636308) | Peking University | 2018-07-17 |
| Eus-guided Cryothermal Ablation in Stage III Pancreatic Adenocarcinoma (NCT03649035) | Istituto Clinico Humanitas | 2018-07-12 |
| Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer (NCT03638193) | Shenzhen BinDeBio Ltd. | 2018-07-11 |
| Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy (NCT03398291) | Fudan University | 2018-07-01 |
| Two Chemotherapy Regimens Plus or Minus Bevacizumab (NCT03351296) | Gustave Roussy, Cancer Campus, Grand Paris | 2018-06-26 |
| Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial (NCT03322995) | Medical College of Wisconsin | 2018-06-21 |
| Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy (NCT03515356) | University of Michigan Rogel Cancer Center | 2018-06-13 |
| VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma (NCT03556228) | VM Oncology, LLC | 2018-06-08 |
| Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos (NCT03668418) | University of Pisa | 2018-06-01 |
| Application of Newly Developed Endoscopic Ultrasound With Zone Sonography Technology for Diagnosis of Pancreatic Caner (NCT03933111) | Changhai Hospital | 2018-06-01 |
| Personal Resilience Empowerment Program Study (NCT03644173) | Hackensack Meridian Health | 2018-05-30 |
| Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors (NCT03490669) | AstraZeneca | 2018-05-21 |
| M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas (NCT03451773) | National Cancer Institute (NCI) | 2018-05-17 |
| A Study of Photon and Proton Chemoradiotherapy as Definitive or Neoadjuvant Therapy in Non-Metastatic Pancreatic Cancer (NCT03902600) | Mayo Clinic | 2018-05-10 |
| Improving REsectability in Pancreatic NEoplasms (IRENE) (NCT03460925) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2018-05-02 |
| A Study in Postoperative Pancreatic Fistula (NCT03129607) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2018-05-01 |
| Drug Screening of Pancreatic Cancer Organoids Developed From EUS-FNA Guided Biopsy Tissues (NCT03544255) | Ying Lv | 2018-05-01 |
| Chyle Leak After Pancreatic Operation (NCT03127150) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2018-05-01 |
| Use of High-dose Radiation Therapy Plus Chemotherapy to Improve the Likelihood of Surgical Treatment in Patients With Locally Advanced Pancreatic Cancer (NCT03523312) | Memorial Sloan Kettering Cancer Center | 2018-04-30 |
| GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors (NCT03576131) | Genmab | 2018-04-30 |
| CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers (NCT03454451) | Corvus Pharmaceuticals, Inc. | 2018-04-25 |
| SurePathTM Liquid-based Cytology and Conventional Smear Cytology in Pancreatic Lesions (NCT03606148) | Seoul National University Hospital | 2018-04-17 |
| Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer (NCT03300843) | National Cancer Institute (NCI) | 2018-04-11 |
| Gemcitabine and Celecoxib Combination Therapy in Treating Patients With R0 Resection Pancreatic Cancer (NCT03498326) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2018-04-02 |
| A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer (NCT03512756) | Tyme, Inc | 2018-03-27 |
| EUS Evaluation of CBD Diameter in Malignant Obstructive Jaundice (NCT03494023) | Clinical Hospital Colentina | 2018-03-27 |
| In Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic Cancer (NCT03492164) | Abramson Cancer Center at Penn Medicine | 2018-03-20 |
| A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer (NCT01676259) | Silenseed Ltd | 2018-03-07 |
| Divestment for Artery-involved Pancreatic Cancer (NCT03443921) | The First Affiliated Hospital with Nanjing Medical University | 2018-03-01 |
| Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms (NCT03435770) | Singapore General Hospital | 2018-03-01 |
| Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies (NCT03638206) | Shenzhen BinDeBio Ltd. | 2018-03-01 |
| IMX-110 in Patients With Advanced Solid Tumors (NCT03382340) | Immix Biopharma Australia Pty Ltd | 2018-02-15 |
| Pilot Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in Combination With GC4419 in Pancreatic Cancer (NCT03340974) | Galera Therapeutics, Inc. | 2018-02-12 |
| GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer (NCT03161379) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-02-02 |
| Safety and Efficacy of an Ablation Catheter for the Treatment of Pancreatic Premalignant Cyctic Lesions. (NCT03417843) | HaEmek Medical Center, Israel | 2018-02-01 |
| Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD) (NCT03415854) | HonorHealth Research Institute | 2018-01-31 |
| Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors (NCT03454035) | UNC Lineberger Comprehensive Cancer Center | 2018-01-30 |
| Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy (NCT03407040) | National Cancer Institute (NCI) | 2018-01-30 |
| Evaluation of GEMCITEST in Patients With Pancreatic Cancer and Treated by Chemotherapy (NCT03599154) | Centre Georges Francois Leclerc | 2018-01-30 |
| Use of Epidurals Intraoperatively for Patients Undergoing Pancreas Resection (NCT03434678) | Memorial Sloan Kettering Cancer Center | 2018-01-30 |
| A Study of ASN007 in Patients With Advanced Solid Tumors (NCT03415126) | Asana BioSciences | 2018-01-19 |
| A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus (NCT03937453) | Nuvance Health | 2018-01-19 |
| TAA Specific Cytotoxic T Lymphocytes in Patients With Pancreatic Cancer (NCT03192462) | Baylor College of Medicine | 2018-01-18 |
| FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors (NCT03319459) | Fate Therapeutics | 2018-01-18 |
| Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic Cancer (NCT03316599) | Dana-Farber Cancer Institute | 2018-01-17 |
| Optical and Biochemical Biomarkers in Early Pancreatic Cancer (NCT03404661) | Mayo Clinic | 2018-01-11 |
| A Trial of PEGPH20 in Combination With Avelumab in Chemotherapy Resistant Pancreatic Cancer (NCT03481920) | PH Research, S.L. | 2018-01-10 |
| POstopeRative Standardization of Care: THe Implementation of Best Practice After Pancreatic Resection (NCT03400280) | St. Antonius Hospital | 2018-01-08 |
| Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy (NCT03122106) | Washington University School of Medicine | 2018-01-05 |
| MicroRNAs as Bile-based Biomarkers in Pancreaticobiliary Cancers (NCT06258824) | Imperial College London | 2018-01-01 |
| Signature for Precise Chemosensitivity Prediction in PDAC (NCT06461598) | Ruijin Hospital | 2018-01-01 |
| Modified Wet Suction Versus Capillary Techniques for EUS Guided Fine Needle Aspiration and Biopsy of Solid Lesions (NCT02919553) | Loma Linda University | 2018-01-01 |